Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.28-0.19 (-2.94%)
At close: 04:00PM EDT
6.25 -0.03 (-0.48%)
After hours: 07:55PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1010109
Avg. Estimate-0.17-0.14-0.6-0.34
Low estimate-0.32-0.18-0.74-0.82
High estimate-0.14-0.1-0.51-0.08
Year ago EPS-0.4-0.19-1.18-0.6
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts99109
Avg. Estimate98.47M103.34M402.57M475.16M
Low estimate96.66M101.5M395M383M
High estimate101.09M105.81M408.07M512.18M
Year ago sales82.49M85.95M331.41M402.57M
Sales growth (year/est)19.40%20.20%21.50%18.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.23-0.23-0.24-0.21
Actual EPS-0.4-0.19-0.31-0.17
Difference-0.170.04-0.070.04
Surprise %-73.90%17.40%-29.20%19.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.14-0.6-0.34
7 days ago-0.17-0.14-0.62-0.37
30 days ago-0.16-0.13-0.62-0.34
60 days ago-0.16-0.13-0.61-0.34
90 days ago-0.16-0.15-0.72-0.39
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3473
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.57.50%N/AN/AN/A
Next qtr.26.30%N/AN/AN/A
Current year49.20%N/AN/AN/A
Next year43.30%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A